This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Cancer Center. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yeonsu Lee: Innovator in Oncolytic Virus Research
Introduction
Yeonsu Lee is a prominent inventor based in Gimpo-si, South Korea. She has made significant contributions to the field of oncolytic virus research, focusing on enhancing the efficacy of viral therapies for cancer treatment. Her innovative work has led to the development of a unique composition that improves oncolytic virus activity.
Latest Patents
Yeonsu Lee holds a patent for a composition comprising NC886 aimed at improving oncolytic virus activity or production. The present invention relates to a composition for enhancing oncolytic virus activity, which comprises nc886, and a composition for enhancing virus production that includes the same. This patent highlights her commitment to advancing cancer treatment methodologies.
Career Highlights
Yeonsu Lee is affiliated with the National Cancer Center, where she conducts her research and development activities. Her work at this esteemed institution underscores her dedication to finding innovative solutions in the fight against cancer.
Collaborations
Some of her notable coworkers include Yongsun Lee and Inhoo Kim, who collaborate with her on various research projects. Their combined expertise contributes to the advancement of oncolytic virus therapies.
Conclusion
Yeonsu Lee's contributions to oncolytic virus research exemplify her innovative spirit and commitment to improving cancer treatment. Her patent and work at the National Cancer Center position her as a key figure in the ongoing battle against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile